Mgr. Petr Lapčík, Ph.D.
Researcher II, Department of Biochemistry
Correspondence Address:
Kotlářská 267/2, 611 37 Brno
E‑mail: |
---|
Total number of publications: 38
2023
-
Proteogenomic Classification of Triple-Negative Breast Cancer for Prognosis and Targeted Therapy
Year: 2023, type: Conference abstract
-
Proteotype classification of localized and metastatic renal cell carcinoma for prognosis and therapy response
Year: 2023, type: Conference abstract
-
Proteotype classification of metastatic and localized renal cell carcinomas for prognosis and therapy response
Year: 2023, type: Conference abstract
-
Proteotypová klasifikace renálního karcinomu
Year: 2023, type:
-
Transmembrane glycoprotein GPNMB is a potential marker of poor response of metastatic renal cell carcinoma to tyrosine kinase receptor inhibitor treatment
Year: 2023, type: Conference abstract
2022
-
A large-scale assay library for targeted protein quantification in renal cell carcinoma tissues
Proteomics, year: 2022, volume: 22, edition: 7, DOI
-
DIA-MS identifies proteins associated with a poor response of metastatic renal cell carcinoma to tyrosine kinase inhibitor treatment
Year: 2022, type: Conference abstract
-
Global SEC-PCP-SILAC mapping reveals protein complexes mediating NF-κB activation in breast cancer
Year: 2022, type: Conference abstract
-
Characterization of the AGR2 Interactome Uncovers New Players of Protein Disulfide Isomerase Network in Cancer Cells
Molecular & Cellular Proteomics, year: 2022, volume: 21, edition: 2, DOI
-
Proteiny odpovědné za špatnou terapeutickou odpověď metastatických nádorů ledvin na léčbu tyrosinkinasovými inhibitory
Year: 2022, type: Conference abstract